Author

Vladimir Makarov

Cleveland ClinicORCID 0000-0001-9622-1550Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Vladimir Makarov2 papers · Cleveland Clinic

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Angela H. TingiD· 1 shared Arvind RaviiD· 1 shared Booki MiniD· 1 shared Byron LeeiD· 1 shared Emily E. FinkiD· 1 shared Gad A. GetziD· 1 shared Hong QiuiD· 1 shared Ivan JurićiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angela H. TingORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyThe Journal of ImmunologyPeer-reviewedMar 1, 2026

Strain-level antigen variation facilitates immune evasion in Bacteroides thetaiotaomicron

Robert W. P. Glowacki, Jessica M. Till, Orion D. Brock…·Philip P. Ahern

This study identifies strain-level antigen variation in Bacteroides thetaiotaomicron that enables immune evasion by CD4+ T cells, revealing a mechanism for strain discrimination in the microbiome.

1 citation

mouseexperimental assay

𝕏 PostBluesky

Cancer Biologynpj Precision OncologyPeer-reviewedSep 26, 2025

Single Cell RNA-sequencing of BCG naive and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM mediated immune-suppressive pathway

Ivan Jurić, Emily E. Fink, Hong Qiu…·Byron Lee

This study uses single-cell RNA sequencing to identify a CD6/ALCAM-mediated immune-suppressive pathway in recurrent NMIBC, suggesting CD6 as a potential therapeutic target.

6 citationstop 3%

𝕏 PostBluesky